64.17
前日終値:
$64.23
開ける:
$64.23
24時間の取引高:
703.90K
Relative Volume:
0.43
時価総額:
$7.78B
収益:
$12.50B
当期純損益:
$314.00M
株価収益率:
26.30
EPS:
2.44
ネットキャッシュフロー:
$421.00M
1週間 パフォーマンス:
+1.40%
1か月 パフォーマンス:
-5.57%
6か月 パフォーマンス:
-0.62%
1年 パフォーマンス:
-9.91%
Henry Schein Inc Stock (HSIC) Company Profile
HSIC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HSIC
Henry Schein Inc
|
64.14 | 7.79B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
MCK
Mckesson Corporation
|
790.28 | 97.93B | 377.60B | 3.35B | 5.67B | 25.06 |
![]()
COR
Cencora Inc
|
329.97 | 63.75B | 316.65B | 1.91B | 1.14B | 9.7209 |
![]()
CAH
Cardinal Health Inc
|
159.46 | 37.70B | 222.58B | 1.57B | 1.85B | 6.4395 |
![]()
AHG
Akso Health Group Adr
|
1.60 | 895.20M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-26 | アップグレード | Evercore ISI | In-line → Outperform |
2025-07-25 | ダウングレード | Stifel | Buy → Hold |
2025-07-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2025-02-14 | 開始されました | Wells Fargo | Equal Weight |
2025-01-06 | アップグレード | BofA Securities | Underperform → Buy |
2024-12-04 | 開始されました | Mizuho | Neutral |
2024-07-22 | アップグレード | Robert W. Baird | Neutral → Outperform |
2024-02-26 | 開始されました | Leerink Partners | Market Perform |
2023-12-12 | アップグレード | JP Morgan | Neutral → Overweight |
2023-11-10 | アップグレード | Stifel | Hold → Buy |
2022-08-08 | アップグレード | UBS | Sell → Neutral |
2022-07-21 | ダウングレード | Goldman | Buy → Neutral |
2022-06-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2022-05-13 | 再開されました | Credit Suisse | Outperform |
2022-01-31 | 開始されました | Morgan Stanley | Underweight |
2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
2021-10-01 | 再開されました | Credit Suisse | Neutral |
2021-02-08 | 再開されました | Piper Sandler | Overweight |
2021-01-04 | アップグレード | Robert W. Baird | Neutral → Outperform |
2020-11-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2020-04-07 | アップグレード | Goldman | Neutral → Buy |
2020-04-02 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2020-01-09 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2020-01-02 | アップグレード | Evercore ISI | Underperform → In-line |
2019-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
2019-05-30 | 開始されました | Wolfe Research | Underperform |
2019-05-15 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2019-04-18 | 開始されました | Guggenheim | Buy |
2019-01-17 | 開始されました | UBS | Sell |
2019-01-03 | ダウングレード | Evercore ISI | In-line → Underperform |
2019-01-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2018-11-08 | 繰り返されました | Barrington Research | Outperform |
2018-10-25 | ダウングレード | Edward Jones | Hold → Sell |
2018-10-19 | 再開されました | Goldman | Neutral |
2018-10-04 | 繰り返されました | Robert W. Baird | Outperform |
2018-08-07 | 繰り返されました | Stifel | Hold |
2018-04-24 | ダウングレード | Goldman | Buy → Neutral |
2018-04-04 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
すべてを表示
Henry Schein Inc (HSIC) 最新ニュース
Henry Schein to Present at November Conferences - Dentistry Today
Henry Schein (Nasdaq: HSIC) to present at Stifel Nov 12, Jefferies Nov 18; live webcasts - Stock Titan
Henry Schein to Participate in Upcoming Investor Conferences in November - Bluefield Daily Telegraph
Will earnings trigger a reversal in Henry Schein Inc.July 2025 Reactions & Consistent Return Strategy Ideas - newser.com
Analyzing drawdowns of Henry Schein Inc. with statistical toolsMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Has Henry Schein Inc. found a price floorGDP Growth & Stock Portfolio Risk Control - newser.com
Will Henry Schein Inc. bounce back from current support2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Henry Schein to Report Q3 2025 Earnings - Dentistry Today
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET - BioSpace
Earnings Preview: What to Expect From Henry Schein’s Report - inkl
Why Henry Schein Inc. stock could be next big winnerTrade Entry Report & Fast Exit and Entry Trade Guides - nchmf.gov.vn
Understanding Henry Schein Inc.’s price movementLong Setup & Fast Momentum Entry Tips - newser.com
Is Henry Schein Inc. stock bottoming outTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo
Can Henry Schein Inc. stock hit analyst price targetsDollar Strength & Fast Gain Stock Trading Tips - newser.com
Chart based analysis of Henry Schein Inc. trendsLayoff News & Weekly Momentum Stock Picks - newser.com
Henry Schein Inc Stock Analysis and ForecastReal-Time Stock Alerts & Capitalize On Momentum - earlytimes.in
Why Henry Schein Inc. stock is trending among retail traders2025 Technical Patterns & Fast Entry Momentum Trade Alerts - nchmf.gov.vn
Gains Recap: Why Henry Schein Inc. stock is considered a top pickWeekly Earnings Recap & Free Accurate Trade Setup Notifications - nchmf.gov.vn
Henry Schein (HSIC): Evaluating Valuation After New Biomerica Deal and Analyst Downgrade - Sahm
How Henry Schein Inc. stock responds to policy changesWeekly Trend Report & Daily Risk Controlled Trade Plans - nchmf.gov.vn
Why Henry Schein Inc. stock is considered a top pickMarket Performance Summary & Free Long-Term Investment Growth Plans - nchmf.gov.vn
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
What dividend safety score for Henry Schein Inc. stockWeekly Investment Summary & Growth Focused Entry Point Reports - nchmf.gov.vn
S P Trends: What dividend safety score for Henry Schein Inc. stockMarket Sentiment Report & Community Consensus Picks - nchmf.gov.vn
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S. - MarketScreener
Henry Schein (HSIC) Gets a Hold from Leerink Partners - The Globe and Mail
Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Healt... - ADVFN
Henry Schein Announces $400 Million Increase to Share Repurchase Plan - ADVFN
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. - ADVFN
How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative - Yahoo Finance
Assessing Henry Schein (HSIC) Valuation After Recent Share Price Decline - Yahoo Finance
TAG Expands Tech With Planmeca Partnership - Dentistry Today
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's Infoods®? Ibs Test in the U.S - MarketScreener
Biomerica (BMRA) Partners with Henry Schein to Expand IBS Test R - GuruFocus
Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US - MarketScreener
Henry Schein and Biomerica enter into marketing services agreement for Biomerica's inFoods IBS Test in the US - MarketScreener
59.6% of treated patients hit FDA abdominal pain endpoint; Biomerica, Henry Schein to market inFoods® in U.S. (ex NY) - Stock Titan
CFRA downgrades Henry Schein (HSIC) to a Sell - The Globe and Mail
Henry Schein Inc (HSIC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):